As of 2024-12-12, the EV/EBITDA ratio of Acerus Pharmaceuticals Corporation (ASP.TO) is -2.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASP.TO's latest enterprise value is 63.81 mil CAD. ASP.TO's TTM EBITDA according to its financial statements is -25.78 mil CAD. Dividing these 2 quantities gives us the above ASP.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.4x - 4.5x | 4.3x |
| Forward P/E multiples | 3.4x - 5.3x | 4.3x |
| Fair Price | (24.21) - (29.32) | (28.28) |
| Upside | -6824.8% - -8245.5% | -7956.1% |
| Date | EV/EBITDA |